WS Investor
24 Sep 2026, 19:45
Welltower Rises as JPMorgan Upgrades Stock to Overweight
Welltower (NYSE: WELL) shares rose about 2.1% after JPMorgan upgraded the healthcare REIT to Overweight from Neutral while maintaining a $260 price target.
Analyst Michael Mueller cited Welltower’s “visible, multi-year, outsized growth” outlook, with the company’s same-store net operating income growth continuing to stand out both within the healthcare real estate segment and across the broader REIT universe. The upgrade reflects JPMorgan’s expectation that strong senior-housing fundamentals and above-average property-level growth can continue supporting earnings expansion (The Fly/TipRanks)
Welltower shares were trading around $234.59, up roughly 2.1%. JPMorgan’s unchanged $260 target remains above the current share price.
Welltower (NYSE: WELL) shares rose about 2.1% after JPMorgan upgraded the healthcare REIT to Overweight from Neutral while maintaining a $260 price target.
Analyst Michael Mueller cited Welltower’s “visible, multi-year, outsized growth” outlook, with the company’s same-store net operating income growth continuing to stand out both within the healthcare real estate segment and across the broader REIT universe. The upgrade reflects JPMorgan’s expectation that strong senior-housing fundamentals and above-average property-level growth can continue supporting earnings expansion (The Fly/TipRanks)
Welltower shares were trading around $234.59, up roughly 2.1%. JPMorgan’s unchanged $260 target remains above the current share price.
